Services of Infectious Diseases and AIDS Unit

Spain

Services of Infectious Diseases and AIDS Unit

Spain
SEARCH FILTERS
Time filter
Source Type

Gil C.,AIDS Research Group | Climent N.,AIDS Research Group | Garcia F.,AIDS Research Group | Garcia F.,Services of Infectious Diseases and AIDS Unit | And 22 more authors.
Vaccine | Year: 2011

This study provides a detailed description and characterization of the preparation of individualized lots of autologous heat inactivated HIV-1 virions used as immunogen in a clinical trial designed to test an autologous dendritic-cell-based therapeutic HIV-1 vaccine (Clinical Trial DCV-2, NCT00402142). For each participant, ex vivo isolation and expansion of primary virus were performed by co-culturing CD4-enriched PBMCs from the HIV-1-infected patient with PBMC from HIV-seronegative unrelated healthy volunteer donors. The viral supernatants were heat-inactivated and concentrated to obtain 1mL of autologous immunogen, which was used to load autologous dendritic cells of each patient. High sequence homology was found between the inactivated virus immunogen and the HIV-1 circulating in plasma at the time of HIV-1 isolation. Immunogens contained up to 10 9 HIV-1 RNA copies/mL showed considerably reduced infectivity after heat inactivation (median of 5.6log 10), and were free of specified adventitious agents. The production of individualized lots of immunogen based on autologous inactivated HIV-1 virus fulfilling clinical-grade good manufacturing practice proved to be feasible, consistent with predetermined specifications, and safe for use in a clinical trial designed to test autologous dendritic cell-based therapeutic HIV-1 vaccine. © 2011 Elsevier Ltd.

Loading Services of Infectious Diseases and AIDS Unit collaborators
Loading Services of Infectious Diseases and AIDS Unit collaborators